{"nct_id":"NCT06033261","title":"A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes","status":"COMPLETED","status_verified_date":"2025-05","start_date":"2023-09-06","start_date_type":"ACTUAL","primary_completion_date":"2025-04-25","primary_completion_date_type":"ACTUAL","completion_date":"2025-04-25","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["MRNA"]}